⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVO News
Novo-Nordisk A/S
U.S. Pharmaceutical Market to Reach USD 965 Billion by 2035
globenewswire.com
ABT
BIIB
BMY
GILD
GSK
LLY
MRK
NVS
NVO
PFE
SNY
Novo Nordisk to present new data on Wegovy®, women with obesity and next-generation weight loss treatments at European Congress on Obesity
globenewswire.com
NVO
FormBlends Publishes 2026 State of Peptides Report as RFK-Era HHS Signals Major Shifts for GLP-1 and Peptide Therapy Access in the United States
globenewswire.com
LLY
NVO
BMY
AMGN
AZN
PFE
ALT
Union Pacific Recognizes 138 Companies with Pinnacle Award for Safely Shipping Hazardous Materials
businesswire.com
UNP
ADM
AVT
BG
CE
CF
CL
CTVA
DD
DOW
DVN
ECL
EM
EQT
XOM
FCX
HOG
HPE
HRI
HVT
ICE
IFF
INV
IVZ
JCI
JNJ
KMB
KO
LIN
LPCN
LYB
MDT
MEOH
MGM
MMC
MMM
MO
MSFT
NKE
NOC
NOV
NVR
NVS
NVO
NXT
OIS
OKE
OLN
OMC
ORCL
ORLY
OSK
OTIS
OVV
OXM
OXY
PAG
PAHC
PAR
PCAR
PEG
PEP
PFG
PGR
PH
PHG
PII
PLD
PM
PNC
PNW
PPG
PPL
PRGO
PRU
PSA
PSX
PVH
PWR
PX
PYPL
QCOM
RCL
RDN
REG
RF
RHI
RIVN
RL
RMD
RNR
ROK
ROL
ROST
RRC
RS
RTX
S
SABR
SAN
SBUX
SCHW
SEE
SEIC
SHW
SI
SIBN
SIG
SIRI
SITE
SLB
SMG
SNA
SNOW
SNY
SO
SON
SONO
SPG
SPGI
SPRO
SQM
SRG
SSNC
ST
STAG
STE
STG
STI
STLD
STNG
STX
STZ
SUI
SUN
SW
SWK
SWX
SY
SYK
SYY
T
TAC
TAL
TBBK
TCI
TD
TDC
TDG
TDOC
TECK
TEF
TEL
TEN
TER
TEX
TFC
TFX
TGT
THC
THO
TJX
TKR
TLRY
TMO
TNC
TNK
TNL
TOL
TOPS
TORO
TPB
TPG
TPH
TR
TRC
TRI
TRMB
TRN
TROX
TRP
TRS
TRT
TRV
TS
TSLA
TTC
TTI
TTWO
TV
TW
TWIN
TWLO
TX
TXN
TXT
TYL
TZOO
U
UAA
UAL
UAN
UDR
UEC
UFPI
UG
UHAL
UHS
UL
ULTA
UMC
UMH
UNF
UNH
UNIT
UNM
UONE
URBN
USFD
USNA
USPH
UTHR
UTL
UVV
V
VAL
VALE
VRTX
VTR
W
WAB
WBS
WCC
WCN
WDC
WEC
WEN
WFC
WFG
WGO
WHD
WHR
WMB
WMG
WMT
WPC
WPP
WRLD
WRN
WSBC
WSC
WSFS
WST
WTFC
WTI
WTS
WU
WVE
WWD
WWW
XCUR
XPO
XRAY
XRX
XYL
YETI
YMM
YUM
Z
ZBH
ZBRA
ZION
ZNTL
ZTS
Novo Nordisk A/S - share repurchase programme
globenewswire.com
NVO
Spherix Global Insights Finds Specialty Split in Perceptions of Direct-to-Patient Platforms for Obesity Treatment
globenewswire.com
LLY
NVO
Global Perfusion Systems Market to Register Incremental Growth at a CAGR of ~5% by 2034 | DelveInsight
globenewswire.com
MDT
LIVN
BSX
THC
AMGN
AZN
PFE
JNJ
MRNA
BMY
GILD
REGN
TEVA
CL
PG
KO
PEP
DIS
NVDA
GOOG
AMZN
MSFT
AAPL
TSLA
META
CRM
ADBE
NFLX
INTC
AMD
QCOM
CMCSA
T
VZ
IBM
ORCL
CSCO
ACN
HON
GE
BA
CAT
XOM
CVX
JPM
BAC
WFC
C
GS
MS
AXP
V
MA
HD
MCD
SBUX
COST
WMT
TGT
LOW
CVS
UNH
CI
ETSY
ROKU
PYPL
MELI
EBAY
BABA
JD
PDD
NTES
BIDU
TM
SONY
SAP
AIR
ASML
BNTX
NVO
BP
FCX
BHP
RIO
VALE
NKE
LULU
UA
CROX
NOC
GD
LMT
RTX
AVGO
AMAT
LRCX
MU
NXPI
MRVL
SNPS
CDNS
VRTX
BIIB
LLY
ABBV
MRK
CHTR
CMG
SIRI
GEHC
GSK
SNY
MREO
Exert BodySculpt Addresses Rise in Buffalo Hump Cases Linked to GLP-1 Weight Loss Drugs
globenewswire.com
LLY
NVO
The Longevity Trade Is No Longer a Buzzword — It's a $120 Billion Market, and the FDA Just Cleared the First Cellular Rejuvenation Trial
globenewswire.com
LLY
NVO
VKTX
LGVN
Novo Nordisk’s oral semaglutide demonstrates potential to be the first oral GLP-1 RA therapy for children and adolescents with type 2 diabetes
globenewswire.com
NVO